These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11967516)

  • 1. Effects of the selective estrogen receptor modulator, raloxifene, on carotid artery pulsatility index in postmenopausal women.
    Setacci C; la Marca A; Agricola E; Morgante G; Setacci F; Cappelli A; Petraglia F; De Leo V
    Am J Obstet Gynecol; 2002 Apr; 186(4):832-5. PubMed ID: 11967516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women.
    Saitta A; Altavilla D; Cucinotta D; Morabito N; Frisina N; Corrado F; D'Anna R; Lasco A; Squadrito G; Gaudio A; Cancellieri F; Arcoraci V; Squadrito F
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1512-9. PubMed ID: 11557681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raloxifene therapy does not affect uterine blood flow in postmenopausal women: a transvaginal Doppler study.
    de Azevedo GD; do Prado MF; Ferriani RA; dos Reis RM; Berezowski AT; Ribeiro TF; Silva E; de Oliveira Maranhão TM; Silva de Sá MF
    Maturitas; 2004 Mar; 47(3):195-200. PubMed ID: 15036489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transvaginal color Doppler sonographic evaluation of the uterus in postmenopausal women on daily raloxifene therapy.
    Chittacharoen A; Theppisai U; Manonai J
    Climacteric; 2002 Jun; 5(2):156-9. PubMed ID: 12051111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.
    De Leo V; la Marca A; Morgante G; Lanzetta D; Setacci C; Petraglia F
    Am J Obstet Gynecol; 2001 Feb; 184(3):350-3. PubMed ID: 11228485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugated equine estrogen, raloxifene and arterial stiffness in postmenopausal women.
    Dias AR; de Mello NR; Eluf Gebara OC; Nussbacher A; Wajngarten M; Petti DA
    Climacteric; 2008 Oct; 11(5):390-6. PubMed ID: 18781483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raloxifene reduces impedance to flow within the uterine artery in early postmenopausal women: a 2-year randomized, placebo-controlled, comparative study.
    Post MS; van der Mooren MJ; van Baal WM; Neele SJ; Netelenbos JC; Kenemans P
    Am J Obstet Gynecol; 2001 Sep; 185(3):557-62. PubMed ID: 11568777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of raloxifene on brachial arterial endothelial function, carotid wall thickness, and arterial stiffness in osteoporotic postmenopausal women.
    Sumino H; Ichikawa S; Kasama S; Takahashi T; Sakamoto H; Koizumi A; Kanai H; Araki Y; Itoh T; Iwasaki T; Sawada Y; Saito Y; Kumakura H; Takayama Y; Kanda T; Murakami M; Sakamaki T; Kurabayashi M
    Int Heart J; 2010 Jan; 51(1):60-7. PubMed ID: 20145354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women.
    Ceresini G; Marchini L; Rebecchi I; Morganti S; Bertone L; Montanari I; Bacchi-Modena A; Sgarabotto M; Baldini M; Denti L; Ablondi F; Ceda GP; Valenti G
    Atherosclerosis; 2003 Mar; 167(1):121-7. PubMed ID: 12618276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carotid artery intima-media thickness after raloxifene treatment.
    Mack WJ; Dhungana B; Dowsett SA; Keech CA; Feng M; Li Y; Hodis HN
    J Womens Health (Larchmt); 2007 Apr; 16(3):370-8. PubMed ID: 17439382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of estradiol alone or in combination with cyproterone acetate on carotid artery pulsatility index in postmenopausal women.
    De Leo V; la Marca A; Orlandi R; Crippa D; Setacci C; Petraglia F
    Maturitas; 2003 Nov; 46(3):219-24. PubMed ID: 14585525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indicators of lifetime estrogen exposure: effect on breast cancer incidence and interaction with raloxifene therapy in the multiple outcomes of raloxifene evaluation study participants.
    Lippman ME; Krueger KA; Eckert S; Sashegyi A; Walls EL; Jamal S; Cauley JA; Cummings SR
    J Clin Oncol; 2001 Jun; 19(12):3111-6. PubMed ID: 11408508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk.
    Cerquetani E; Vitale C; Mercuro G; Fini M; Zoncu S; Rosano GM
    Gynecol Endocrinol; 2004 Jun; 18(6):291-8. PubMed ID: 15497491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of raloxifene on endothelium-dependent dilation, lipoproteins, and markers of vascular function in postmenopausal women with coronary artery disease.
    Griffiths KA; Sader MA; Skilton MR; Harmer JA; Celermajer DS
    J Am Coll Cardiol; 2003 Aug; 42(4):698-704. PubMed ID: 12932604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of raloxifene hydrochloride.
    Saitta A; Morabito N; Frisina N; Cucinotte D; Corrado F; D'Anna R; Altavilla D; Squadrito G; Minutoli L; Arcoraci V; Cancellieri F; Squadrito F
    Cardiovasc Drug Rev; 2001; 19(1):57-74. PubMed ID: 11314601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women.
    Weinstein RS; Parfitt AM; Marcus R; Greenwald M; Crans G; Muchmore DB
    Osteoporos Int; 2003 Oct; 14(10):814-22. PubMed ID: 14610642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium-a pilot study.
    Davis SR; O'Neill SM; Eden J; Baber R; Ekangaki A; Stocks JM; Thiebaud D
    Menopause; 2004; 11(2):167-75. PubMed ID: 15021446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 12-month comparative study of raloxifene, estrogen, and placebo on the postmenopausal endometrium.
    Goldstein SR; Scheele WH; Rajagopalan SK; Wilkie JL; Walsh BW; Parsons AK
    Obstet Gynecol; 2000 Jan; 95(1):95-103. PubMed ID: 10636510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
    Usall J; Huerta-Ramos E; Labad J; Cobo J; Núñez C; Creus M; Parés GG; Cuadras D; Franco J; Miquel E; Reyes JC; Roca M;
    Schizophr Bull; 2016 Mar; 42(2):309-17. PubMed ID: 26591005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration in the pulsatility index values of the internal carotid and middle cerebral arteries after suspension of postmenopausal hormone replacement therapy: a randomized crossover study.
    Penotti M; Farina M; Castiglioni E; Gaffuri B; Barletta L; Gabrielli L; Vignali M
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):606-11. PubMed ID: 8828422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.